Cytox raises £2.6m led by Catapult Ventures to launch predictive test for Alzheimer’s Disease

Alderley Park, UK – 14 June 2017. Cytox, a leader in genetic testing for Alzheimer’s Disease, today announced that it has raised £2.6m to fund the commercial launch and international roll out of its novel service. The fundin...

Proveca and Tanner Pharma Initiate Global Managed Access Program for Sialanar®

CHARLOTTE, N.C.--(BUSINESS WIRE)--Tanner Pharma Group’s Managed Access Programs (MAP) division and Proveca have agreed to launch a Managed Access Program for an oral formulation of glycopyrronium (Sialanar®) outside Europe and the USA. S...

Blueberry Therapeutics commence Phase I-II clinical trial of lead product BB2603

Blueberry Therapeutics are pleased to announce they have dosed the first patient in a Phase I/II clinical trial of BB2603 in fungal infection of the skin and nail following successful regulatory and ethics approvals. The trial, which is a safety a...

Proveca raises £4m led by Catapult Ventures to launch children’s drug Sialanar in Europe and accelerate children’s medicines pipeline

Manchester, UK – 29th March 2017. Proveca, a European paediatric speciality pharmaceutical company, today announced that it has raised £4m to fund the commercial launch of Sialanar™ and the development and commercialisation...

Growing Chemistry CRO YProtech adds High Potency Capabilities

YProtech, the fast growing contract research organisation (CRO) focused on niche chemistry based services, has installed a high potency facility for the synthesis and manufacture of highly potent cytotoxins for applications in cancer treatment. T...

From our portfolio


Healthcare Technology

viewview our portfolio

Our Team

Corinne Lawrence

view complete team

Contact us

Alderley Park
Alderley Edge
SK10 4TG

Tel: 01625 344300